Table of Contents Author Guidelines Submit a Manuscript
International Journal of Telemedicine and Applications
Volume 2018, Article ID 7937610, 7 pages
https://doi.org/10.1155/2018/7937610
Research Article

Characterizing the Use of Telepsychiatry for Patients with Opioid Use Disorder and Cooccurring Mental Health Disorders in Ontario, Canada

1Northern Ontario School of Medicine, 935 Ramsey Lake Rd., Sudbury, ON, Canada P3E 2C6
2Canadian Addiction Treatment Centers, 13291 Yonge St., Ste. 403., Richmond Hill, ON, Canada L4E 4L6

Correspondence should be addressed to David C. Marsh; ac.mson@hsramd

Received 26 May 2017; Accepted 15 January 2018; Published 11 February 2018

Academic Editor: Malcolm Clarke

Copyright © 2018 Brittanie LaBelle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Madadi, D. Hildebrandt, A. E. Lauwers, and G. Koren, “Characteristics of Opioid-Users Whose Death Was Related to Opioid-Toxicity: A Population-Based Study in Ontario, Canada,” PLoS ONE, vol. 8, no. 4, Article ID e60600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Fischer, A. Ialomiteanu, A. Boak, E. Adlaf, J. Rehm, and R. E. Mann, “Prevalence and key covariates of non-medical prescription opioid use among the general secondary student and adult populations in Ontario, Canada,” Drug and Alcohol Review, vol. 32, no. 3, pp. 276–287, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Brands, “Nonmedical use of opioid analgesics among Ontario students,” Can Fam Physician, vol. 56, no. 3, pp. 256–262, 2010. View at Google Scholar
  4. T. Gomes, M. M. Mamdani, I. A. Dhalla, S. Cornish, J. M. Paterson, and D. N. Juurlink, “The burden of premature opioid-related mortality,” Addiction, vol. 109, no. 9, pp. 1482–1488, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. O. o. t. C. C. o. Ontario, Office of the Chief Coroner Report for 2009-2011, Ministry of Community Safety and Correctional Services Toronto, 2012.
  6. B. Brands et al., Best practicesmethadone maintenance treatment, Health Canada, Ottawa, Canada, 2002.
  7. J. K. Eibl, T. Gomes, D. Martins et al., “Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada,” Journal of Addiction Medicine, vol. 9, no. 6, pp. 440–446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Kurdyak, Universal coverage without universal access: a study of psychiatrist supply and practice patterns in Ontario. Open Med, vol. 8, p. e87-99, 8(3, 2014.
  9. O. M. o. H. a. L.-T. Care, “Telemedicine - Improving access to care through technology,” 2008, http://www.health.gov.on.ca/en/pro/programs/ecfa/action/primary/pri_telemedecine.aspx. View at Google Scholar
  10. T. Molfenter, M. Boyle, D. Holloway, and J. Zwick, “Trends in telemedicine use in addiction treatment,” Addiction science & clinical practice, vol. 10, p. 14, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Stein, Mental Health Addictions... an OTN Overview, Centre for Addiction and Mental Health, 2012.
  12. S. Hall, K. Schulze, P. Groome, W. Mackillop, and E. Holowaty, “Using cancer registry data for survival studies: The example of the Ontario Cancer Registry,” Journal of Clinical Epidemiology, vol. 59, no. 1, pp. 67–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Levy, “Coding accuracy of administrative drug claims in the Ontario Drug Benefit database,” Can J Clin Pharmacol, vol. 10, no. 2, pp. 67–71, 2003. View at Google Scholar
  14. D. N. Juurlink, “Editorial: Proton pump inhibitors and clopidogrel: Putting the interaction in perspective,” Circulation, vol. 120, no. 23, pp. 2310–2312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. D. N. Juurlink, T. Gomes, L. L. Lipscombe, P. C. Austin, J. E. Hux, and M. M. Mamdani, “Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study,” British Medical Journal, vol. 339, Article ID b2942, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mamdani, P. Rochon, D. N. Juurlink et al., “Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly,” JAMA Internal Medicine, vol. 163, no. 4, pp. 481–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. J. K. Eibl, K. Morin, E. Leinonen, and D. C. Marsh, “The state of opioid agonist therapy in canada 20 years after federal oversight,” The Canadian Journal of Psychiatry, vol. 62, no. 7, pp. 444–450, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Mamdani, K. Sykora, P. Li et al., “Reader's guide to critical appraisal of cohort studies: 2. assessing potential for confounding,” British Medical Journal, vol. 330, no. 7497, pp. 960–962, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. LHIN, “Ontario's LHINs,” http://www.lhins.on.ca.
  20. J. K. Eibl, J. Daiter, M. Varenbut, D. Pellegrini, and D. C. Marsh, “Evaluating the effectiveness of telehealth-delivered opioid agonist therapy across Ontario, Canada,” Drug and Alcohol Dependence, vol. 156, p. e63, 2015. View at Publisher · View at Google Scholar
  21. W. A. Hart, Report of the Methadone Maintenance Treatment Practices Task Force.
  22. D. M. Hilty, D. C. Ferrer, M. B. Parish, B. Johnston, E. J. Callahan, and P. M. Yellowlees, “The effectiveness of telemental health: A 2013 review,” Telemedicine and e-Health, vol. 19, no. 6, pp. 444–454, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. L. K. Richardson, B. C. Frueh, A. L. Grubaugh, L. Egede, and J. D. Elhai, “Current directions in videoconferencing tele-mental health research,” Clinical Psychology: Science and Practice, vol. 16, no. 3, pp. 323–338, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. Lindsay, M. R. Kauth, S. Hudson et al., “Implementation of Video Telehealth to Improve Access to Evidence-Based Psychotherapy for Posttraumatic Stress Disorder,” Telemedicine and e-Health, vol. 21, no. 6, pp. 467–472, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Zheng, M. Nickasch, L. Lander et al., “Treatment outcome comparison between telepsychiatry and face-to-face buprenorphine medication-assisted treatment for opioid use disorder: A 2-year retrospective data analysis,” Journal of Addiction Medicine, vol. 11, no. 2, pp. 138–144, 2017. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Krausz, P. Degkwitz, A. Kühne, and U. Verthein, “Comorbidity of opiate dependence and mental disorders,” Addictive Behaviors, vol. 23, no. 6, pp. 767–783, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. S. Cacciola, A. I. Alterman, M. J. Rutherford, J. R. McKay, and F. D. Mulvaney, “The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients,” Drug and Alcohol Dependence, vol. 61, no. 3, pp. 271–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. K. L. Mills, M. Teesson, J. Ross, S. Darke, and M. Shanahan, “The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder,” Psychiatric Services, vol. 56, no. 8, pp. 940–945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Carpentier, P. F. M. Krabbe, M. T. van Gogh, L. J. M. Knapen, J. K. Buitelaar, and C. A. J. de Jong, “Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients,” American Journal on Addictions, vol. 18, no. 6, pp. 470–480, 2009. View at Publisher · View at Google Scholar · View at Scopus